+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monofilament - Global Strategic Business Report

  • PDF Icon

    Report

  • 283 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6093843
The global market for Monofilament was valued at US$1.5 Billion in 2025 and is projected to reach US$2.1 Billion by 2032, growing at a CAGR of 4.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Monofilament Market - Key Trends & Drivers Summarized

What Defines Monofilament and Why Is It Widely Used Across Sectors?

Monofilament refers to a single, continuous strand of synthetic fiber - commonly made from polymers like nylon, polyester, polypropylene, or PTFE - used across a range of applications where strength, uniformity, and resistance to wear are essential. Unlike multifilament yarns, which consist of many fine fibers twisted together, monofilaments are smoother, stiffer, and more abrasion-resistant, making them ideal for products such as fishing lines, lawn trimmer lines, filtration mesh, sutures, and industrial fabrics.

Their uniform diameter and tensile strength provide consistent performance in demanding applications. Monofilaments can be extruded in various diameters and polymer grades, and are engineered to exhibit specific properties such as UV resistance, chemical inertness, and heat stability. As industries increasingly demand high-performance materials that balance mechanical strength with lightweight and corrosion resistance, monofilament continues to expand into both established and emerging product categories.

How Are Material and Process Innovations Shaping Monofilament Capabilities?

Advancements in polymer science and extrusion technology are enabling manufacturers to produce monofilaments with enhanced strength-to-weight ratios, lower elongation, and improved processability. Modified additives and surface coatings are being used to reduce friction, improve dyeability, or add flame retardant properties. Precision control of the extrusion process allows for tighter diameter tolerances, essential for applications in medical sutures, automotive components, and aerospace fabrics.

Biodegradable and bio-based monofilaments are gaining momentum as industries seek sustainable alternatives to petroleum-derived plastics. Polylactic acid (PLA) and other compostable polymers are being tested in agricultural nets, packaging, and fishing lines to reduce ocean pollution and environmental impact. In industrial filtration, finer-gauge monofilaments are being combined with high-performance weaves to achieve better particle separation and membrane integrity.

Which End-Use Industries Are Expanding Monofilament Demand?

The medical sector is a key user, relying on monofilament sutures and guide wires that offer strength, minimal tissue drag, and sterilization compatibility. Sports and recreation industries use monofilaments in tennis racket strings, fishing gear, and safety nets, where durability under dynamic loads is critical. In agriculture, they are used in shade nets, anti-insect screens, and trellis supports due to their UV resistance and structural integrity.

Industrial markets consume monofilaments for conveyor belts, filtration meshes, and reinforcement fabrics, particularly in chemical processing, food production, and water treatment. In textiles, monofilaments are used for durable fabrics and embroidery supports, while 3D printing applications are exploring thermoplastic monofilaments for high-precision extrusion. This diversity in end-use segments ensures stable and widespread demand across global supply chains.

The Growth in the Monofilament Market Is Driven by Several Factors

The growth in the monofilament market is driven by several factors including rising demand for lightweight, durable, and high-strength materials in healthcare, agriculture, sports, and industrial processing. Advances in polymer engineering, biodegradable filament development, and high-precision extrusion are enhancing monofilament performance and sustainability. Expansion in protective agriculture, medical device manufacturing, and technical textile production is further supporting demand. As industries prioritize material efficiency, customization, and environmental compliance, monofilament continues to gain relevance as a high-performance, application-flexible material.

Report Scope

The report analyzes the Monofilament market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product Type (Nylon, Polyester, Polyolefin); Application (Fishing & Agriculture, Medical, Textile, Automotive, Wastewater Treatment, Consumer Goods, Other Applications)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Nylon segment, which is expected to reach US$1.3 Billion by 2032 with a CAGR of a 5.3%. The Polyester segment is also set to grow at 3.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $410.1 Million in 2025, and China, forecasted to grow at an impressive 8.0% CAGR to reach $434.2 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Monofilament Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Monofilament Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Monofilament Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as ABC Polymer Industries, LLC, AdvanSix Inc., Ashley Polymers Inc., BASF SE, Daiwa Corporation and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Monofilament market report include:

  • ABC Polymer Industries, LLC
  • AdvanSix Inc.
  • Ashley Polymers Inc.
  • BASF SE
  • Daiwa Corporation
  • Engineered Monofilaments Corporation
  • Evonik Industries AG
  • Hinafil India Ltd.
  • Hyosung Advanced Materials
  • Itochu Corporation
  • Kolon Industries
  • Lanxess AG
  • Momoi Fishing Line
  • NTEC (Nantong NTEC Monofilament Technology Co., Ltd.)
  • NYCOA (New York Chemicals and Plastics)
  • Perlon Monofil GmbH
  • Shakespeare Company, LLC
  • Solvay S.A.
  • Superfil Products Ltd.
  • Toray Industries, Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Morquio Syndrome Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Diagnosis Rates and Improved Genetic Screening Drive Early Identification of Morquio Syndrome
  • Expansion of Orphan Drug Designations Spurs R&D in Enzyme Replacement Therapies (ERTs)
  • OEM Focus on Long-Term Disease Management Supports Development of Targeted Therapies
  • Increased Awareness Campaigns and Advocacy Efforts Strengthen Early Intervention and Drug Uptake
  • Growing Collaboration Between Biopharma Firms and Rare Disease Foundations Enhances R&D Funding
  • Advancements in Biomarker Development Improve Monitoring of Drug Efficacy in MPS IV Patients
  • Push for Home Infusion and Outpatient Administration Models Enhances Treatment Accessibility
  • Pipeline Expansion of Novel Therapeutic Candidates Supports Long-Term Market Outlook
  • Rising Demand for Personalized Medicine Approaches Fuels Development of Genotype-Specific Treatments
  • Global Expansion of Rare Disease Registries Improves Epidemiological Data and Market Targeting
  • OEM Innovation in Chaperone and Gene Therapies Expands Therapeutic Options for Morquio Syndrome
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Morquio Syndrome Drugs Market Analysis of Annual Sales in US$ for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Enzyme Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Hematopoietic Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Morquio A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Morquio B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Solid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Liquid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABC Polymer Industries, LLC
  • AdvanSix Inc.
  • Ashley Polymers Inc.
  • BASF SE
  • Daiwa Corporation
  • Engineered Monofilaments Corporation
  • Evonik Industries AG
  • Hinafil India Ltd.
  • Hyosung Advanced Materials
  • Itochu Corporation
  • Kolon Industries
  • Lanxess AG
  • Momoi Fishing Line
  • NTEC (Nantong NTEC Monofilament Technology Co., Ltd.)
  • NYCOA (New York Chemicals and Plastics)
  • Perlon Monofil GmbH
  • Shakespeare Company, LLC
  • Solvay S.A.
  • Superfil Products Ltd.
  • Toray Industries, Inc.

Table Information